OvaScience Appoints CEO
This article was originally published in Scrip
OvaScience has announced that Harald F. Stock will succeed Michelle Dipp as CEO, who has been appointed executive chair of the company's board – effective July 1, 2016. Stock recently served as president and CEO of Sweden-based long-term care equipment company, ArjoHuntleigh, and he was also executive vice president, extended care business area of Getinge Group. Prior to this, he was the CEO of research-based pharma company, Grünenthal.